The notion on the promoting effect of AMPK on cancer is usually based on the observations under stress settings, while its tumour suppressive function is grounded on the effects of pharmacological activators or AMPK overexpression on bulky tumour. This evidence concerns the gene PRKAA1 and neoplasm.